186 related articles for article (PubMed ID: 16189707)
21. Might E-cadherin promoter polymorphisms of rs16260 and rs5030625 associate with the risk of nephrolithiasis?
Donmez C; Konac E; Aydogan BT; Bilen CY
Springerplus; 2016; 5(1):1673. PubMed ID: 27733975
[TBL] [Abstract][Full Text] [Related]
22. E-cadherin polymorphisms and haplotypes influence risk for prostate cancer.
Bonilla C; Mason T; Long L; Ahaghotu C; Chen W; Zhao A; Coulibaly A; Bennett F; Aiken W; Tullock T; Coard K; Freeman V; Kittles RA
Prostate; 2006 Apr; 66(5):546-56. PubMed ID: 16372334
[TBL] [Abstract][Full Text] [Related]
23. Association of caveolin-1 and -2 genetic variants and post-treatment serum caveolin-1 with prostate cancer risk and outcomes.
Langeberg WJ; Tahir SA; Feng Z; Kwon EM; Ostrander EA; Thompson TC; Stanford JL
Prostate; 2010 Jun; 70(9):1020-35. PubMed ID: 20209490
[TBL] [Abstract][Full Text] [Related]
24. CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer.
Caldeira JR; Prando EC; Quevedo FC; Neto FA; Rainho CA; Rogatto SR
BMC Cancer; 2006 Mar; 6():48. PubMed ID: 16512896
[TBL] [Abstract][Full Text] [Related]
25. Genetic associations of Nrf2-encoding NFE2L2 variants with Parkinson's disease - a multicenter study.
von Otter M; Bergström P; Quattrone A; De Marco EV; Annesi G; Söderkvist P; Wettinger SB; Drozdzik M; Bialecka M; Nissbrandt H; Klein C; Nilsson M; Hammarsten O; Nilsson S; Zetterberg H
BMC Med Genet; 2014 Dec; 15():131. PubMed ID: 25496089
[TBL] [Abstract][Full Text] [Related]
26. Common genetic variation at PTEN and risk of sporadic breast and prostate cancer.
Haiman CA; Stram DO; Cheng I; Giorgi EE; Pooler L; Penney K; Le Marchand L; Henderson BE; Freedman ML
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):1021-5. PubMed ID: 16702386
[TBL] [Abstract][Full Text] [Related]
27. E-cadherin gene polymorphisms and haplotype associated with the occurrence of epithelial ovarian cancer in Chinese.
Li Y; Liang J; Kang S; Dong Z; Wang N; Xing H; Zhou R; Li X; Zhao X
Gynecol Oncol; 2008 Feb; 108(2):409-14. PubMed ID: 18035404
[TBL] [Abstract][Full Text] [Related]
28. A single nucleotide polymorphism in the E-cadherin gene promoter -160 C/A is associated with risk of nasopharyngeal cancer.
Ben Nasr H; Hamrita B; Batbout M; Gabbouj S; Bouaouina N; Chouchane L; Chahed K
Clin Chim Acta; 2010 Sep; 411(17-18):1253-7. PubMed ID: 20462505
[TBL] [Abstract][Full Text] [Related]
29. Single-nucleotide polymorphism in the E-cadherin gene promoter modifies the risk of prostate cancer.
Verhage BA; van Houwelingen K; Ruijter TE; Kiemeney LA; Schalken JA
Int J Cancer; 2002 Aug; 100(6):683-5. PubMed ID: 12209606
[TBL] [Abstract][Full Text] [Related]
30. A novel diffuse gastric cancer susceptibility variant in E-cadherin (CDH1) intron 2: a case control study in an Italian population.
Nasri S; More H; Graziano F; Ruzzo A; Wilson E; Dunbier A; McKinney C; Merriman T; Guilford P; Magnani M; Humar B
BMC Cancer; 2008 May; 8():138. PubMed ID: 18482459
[TBL] [Abstract][Full Text] [Related]
31. Germline variants of base excision repair genes and breast cancer: A polymorphism in DNA polymerase gamma modifies gene expression and breast cancer risk.
Popanda O; Seibold P; Nikolov I; Oakes CC; Burwinkel B; Hausmann S; Flesch-Janys D; Plass C; Chang-Claude J; Schmezer P
Int J Cancer; 2013 Jan; 132(1):55-62. PubMed ID: 22684821
[TBL] [Abstract][Full Text] [Related]
32. Single nucleotide polymorphisms in the promoter region of the E-cadherin gene in gastric cancer: case-control study in a young Mexican population.
Medina-Franco H; Ramos-De la Medina A; Vizcaino G; Medina-Franco JL
Ann Surg Oncol; 2007 Aug; 14(8):2246-9. PubMed ID: 17549573
[TBL] [Abstract][Full Text] [Related]
33. Common variants in mismatch repair genes and risk of invasive ovarian cancer.
Song H; Ramus SJ; Quaye L; DiCioccio RA; Tyrer J; Lomas E; Shadforth D; Hogdall E; Hogdall C; McGuire V; Whittemore AS; Easton DF; Ponder BA; Kjaer SK; Pharoah PD; Gayther SA
Carcinogenesis; 2006 Nov; 27(11):2235-42. PubMed ID: 16774946
[TBL] [Abstract][Full Text] [Related]
34. Sequence variants of elaC homolog 2 (Escherichia coli) (ELAC2) gene and susceptibility to prostate cancer in the Health Professionals Follow-Up Study.
Chen YC; Giovannucci E; Kraft P; J Hunter D
Carcinogenesis; 2008 May; 29(5):999-1004. PubMed ID: 18375959
[TBL] [Abstract][Full Text] [Related]
35. E-cadherin genetic variants predict survival outcome in breast cancer patients.
Memni H; Macherki Y; Klayech Z; Ben-Haj-Ayed A; Farhat K; Remadi Y; Gabbouj S; Mahfoudh W; Bouzid N; Bouaouina N; Chouchane L; Zakhama A; Hassen E
J Transl Med; 2016 Nov; 14(1):320. PubMed ID: 27852262
[TBL] [Abstract][Full Text] [Related]
36. Lack of association between the CDH1 polymorphism and gastric cancer susceptibility: a meta-analysis.
Jiang B; Zhu K; Shao H; Bao C; Ou J; Sun W
Sci Rep; 2015 Jan; 5():7891. PubMed ID: 25599647
[TBL] [Abstract][Full Text] [Related]
37. Genetic variation in the HSD17B1 gene and risk of prostate cancer.
Kraft P; Pharoah P; Chanock SJ; Albanes D; Kolonel LN; Hayes RB; Altshuler D; Andriole G; Berg C; Boeing H; Burtt NP; Bueno-de-Mesquita B; Calle EE; Cann H; Canzian F; Chen YC; Crawford DE; Dunning AM; Feigelson HS; Freedman ML; Gaziano JM; Giovannucci E; Gonzalez CA; Haiman CA; Hallmans G; Henderson BE; Hirschhorn JN; Hunter DJ; Kaaks R; Key T; Le Marchand L; Ma J; Overvad K; Palli D; Pike MC; Riboli E; Rodriguez C; Setiawan WV; Stampfer MJ; Stram DO; Thomas G; Thun MJ; Travis R; Trichopoulou A; Virtamo J; Wacholder S
PLoS Genet; 2005 Nov; 1(5):e68. PubMed ID: 16311626
[TBL] [Abstract][Full Text] [Related]
38. Genetic variants in MGMT and risk of lung cancer in Southeastern Chinese: a haplotype-based analysis.
Hu Z; Wang H; Shao M; Jin G; Sun W; Wang Y; Liu H; Wang Y; Ma H; Qian J; Jin L; Wei Q; Lu D; Huang W; Shen H
Hum Mutat; 2007 May; 28(5):431-40. PubMed ID: 17285603
[TBL] [Abstract][Full Text] [Related]
39. Genetic variation and human longevity.
Soerensen M
Dan Med J; 2012 May; 59(5):B4454. PubMed ID: 22549493
[TBL] [Abstract][Full Text] [Related]
40. Haplotype defined by the MLH1-93G/A polymorphism is associated with MLH1 promoter hypermethylation in sporadic colorectal cancers.
Miyakura Y; Tahara M; Lefor AT; Yasuda Y; Sugano K
BMC Res Notes; 2014 Nov; 7():835. PubMed ID: 25421847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
